Neonatal stem cells: an essential tool for future veterinary practice
Innovative high-tech biotherapies for animal health
Bringing the best of regenerative medicine to as many as possible
Biotherapies developed and manufactured in France in compliance with good practices
A unique know-how in cell therapy
Technologies developed in full compliance with ethics and animal welfare
Précédent
Suivant
Vetbiobank-accueil

1er Etablissement Pharmaceutique Franc?ais de me?decine re?ge?ne?rative ve?te?rinaire

Vetbiobank develops neonatal stem cell-based cellular drugs with unique potential to fight  dogs, cats and horses' chronic inflammatory diseases. Whether they are sick, injured or just old, they help restore their quality of life and well-being.

News

News

Intellectual Property

Vetbiobank deploys its intellectual property protection strategy internationally and expands its patent portfolio with: A regional phase covering high-potential geographical areas and an additional international PCT filing. 

Read more

Events

Events

Meet Vetbiobank at

Virtual Event

 22-23 February,2021

Animal Health Innovation Europe is the leading investment forum for the animal health sector in Europe. It presents the most interesting innovations in the field of animal health and nutrition.

Vetbiobank has been selected to present at the Innovation Show Case session.

Come and meet Vetbiobank's management team

At a Glance

At a Glance

Groupe 5006@2x
0
International
PUBLICATIONS
in 8 years

10
International
PUBLICATIONS
in 8 years

Groupe 5007@2x
0
CLINICAL STUDIES

5
CLINICAL STUDIES

Groupe 5008@2x
0
CLINICAL CASES

1600
TREATMENTS

Groupe 219@2x
1 st
FRENCH PHARMACEUTICAL ESTABLISHMENT
for Veterinary Cellular Therapy

1st
FRENCH PHARMACEUTICAL ESTABLISHMENT
for Veterinary Cellular Therapy

Our Job

Our Job

To develop cellular therapies for veterinary use, to improve and lighten the management of chronic inflammatory animal diseases.

Then to produce them industrially in order to make them accessible to as many people as possible.

Thanks to their intact biological potential linked to their youth, neonatal stem cells can act on the causes responsible for many chronic inflammatory diseases affecting the joints, digestive system, skin, and mucous membranes of animals.

Vetbiobank develops its therapeutic innovations in order to bring: 

to animals, treatments that allow

to pet owners, a solution

to veterinarians, a comlementary expertise

For Veterinarians only

For Veterinarians only

Ask your veterinarian for the price of a stem cell injection at his clinic.

Product Pipeline

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

CANIPREN

VBX-01
Canine osteoarthritis

CA0102
Atopic dermatitis

CA0103
Atopic dermatitis
Chronic
Inflammatory
Bowel
Disease

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

FELIPREN

FE0101
Gingivostomatitis

FE0102
Chronic kidney
failure

FE0103
Feline arthrosis

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

EQUIPREN
OMBISTEM

EQ0101
Equine arthrosis